Published 1 month ago

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers - SOHM (OTC:SHMN)

Summary by Ground News

Coastar Therapeutics and SOHM announce collaboration to advance the field of genome editing using Coastar's red blood cell membrane derived carriers. The collaboration aims to develop a versatile and scalable platform that enables efficient genome editing across various cell types and tissues. This marks a thrilling juncture for both companies and the realm of gene editing.

0 Articles

All

Left

Center

Right

Benzinga

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers - SOHM (OTC:SHMN)

CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC:SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems, and SOHM, a cutting-edge biopharmaceutical compan…

1 month ago·New York, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.